Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Plain language summary of results from the DUO-E study: durvalumab given with or without olaparib in patients with advanced endometrial cancer.
Journal: Future oncology (London, England)
Published: April 07, 2026
Four-year survival outcomes with dostarlimab plus chemotherapy in mismatch repair deficient/microsatellite instability-high primary advanced or recurrent endometrial cancer in the RUBY trial.
Journal: Gynecologic oncology
Published: March 24, 2026
Updated Review for Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection.
Journal: Journal of lower genital tract disease
Published: January 13, 2025
A plain language summary publication of patients' survival with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel.
Journal: Therapeutic advances in medical oncology
Published: December 20, 2024
A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".
Journal: Future oncology (London, England)
Published: July 11, 2024
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 21, 2023
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Journal: The New England journal of medicine
Published: March 27, 2023
Lifestyle intervention in ovarian cancer enhanced survival (LIVES) study (NRG/GOG0225): Recruitment, retention and baseline characteristics of a randomized trial of diet and physical activity in ovarian cancer survivors.
Journal: Gynecologic oncology
Published: September 30, 2022
Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG oncology/GOG study.
Journal: Gynecologic oncology
Published: June 01, 2022
A Roadmap for Participatory Chestnut Breeding for Nut Production in the Eastern United States.
Journal: Frontiers in plant science
Published: July 02, 2021
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 23, 2021
Last Updated: 09/26/2026